97227100
Jan 19, 2022
ADVERUM BIOTECHNOLOGIES INC.
Subscribe
Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of vascular endothelial growth factor (VEGF)-mediated ocular diseases